Wordt geladen...
The biosimilars journey: current status and ongoing challenges
Biosimilar products are already approved and marketed in several countries. The Food and Drug Administration has approved ten different biosimilars, and the European Medicines Agency has approved 40. Even though this scenario has provided important experience with biosimilar products, there are stil...
Bewaard in:
| Gepubliceerd in: | Drugs Context |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioExcel Publishing Ltd
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172013/ https://ncbi.nlm.nih.gov/pubmed/30302115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212543 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|